|
or
click here to
download registration form pdf
SAN FRANCISCO NEUROLOGICAL SOCIETY
SUMMER DINNER MEETING
Tuesday, July 29th
Soizic Bistro
300
Broadway, Oakland, CA
Located at the corner of 3rd Street and Broadway, near Jack
London Square &
Jack London Square Ferry Dock
Tel:
510-251-8100 Street parking available;
parking garage on Washington Street
www.soizicbistro.com
"Pseudotumor
Cerebri",
Robert Egan, MD
St. Helena Hospital, St. Helena, California
6:00 –
6:45PM – Registration and Reception
6:45 – 8:00 PM – Dinner /8:00 – 9:00 PM Presentation
Description:
Pseudotumor Cerebri (PTC) is a disorder found more commonly in overweight
young women associated with increased intracranial pressure and
papilledema. Debate arises regarding the diagnosis when a patient presents
with elevated pressure during a spinal tap without papilledema. Dr. Egan
will discuss the various treatments including weight loss, diuretics,
shunting, and optic nerve fenestration.
Dr. Egan obtained his medical degree from the Medical College of Wisconsin
and then completed a neurology residency and vascular neurology fellowship
at the Oregon Health & Science University. He then completed fellowship
training in neuro-ophthalmology at the Massachusetts Eye & Ear Infirmary
in Boston before returning to OHSU as the Director of Neuro-Ophthalmology
for 8 and 1/2 years. Recently, he left academic medicine for private
practice in the Napa Valley, California, where he continues to see neuro-ophthalmology
patients and is developing a stoke center. His most recent appointment is
spearheading an international task force studying Susac Syndrome, a rare
disorder that is associated with ischemia to the retina, brain, and
cochlea.
Educational Objectives:
Upon completion of this lecture participants should be able to:
-
Participants will be able to identify
perils and pitfalls of the diagnosis of patients with pseudotumor cerebri.
-
Participants will be able to identify
the most appropriate therapy for patients with pseudotumor cerebri.
-
Participants will also understand the
utility of visual field testing in this disorder as well as co-morbid
conditions such as migraine and other headache disorders and the frequent
occurrence of functional vision loss.
Who Should Attend?
Neurologists, neurosurgeons, pain management
specialists, residents and other physicians interested in research and
clinical advances in the neurosciences.
 This is an
activity offered by a CMA-accredited provider. Physicians attending this
course may report up to 1 hour of Category 1 credit toward the
California Medical Association Certificate in Continuing Medical Education
and the American Medical Association’s Physician’s Recognition Award.
ACKNOWLEDGEMENTS:
The San Francisco
Neurological Society gratefully acknowledges support for its 2008
educational activities from the following generous contributors that have
provided:
EDUCATIONAL GRANTS:
Bayer
Healthcare Pharmaceuticals
Biogen Idec
Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
EMD Serono, Inc.
ENDO Pharmaceuticals
Genentech,
Inc.
GlaxoSmithKline
Pfizer
UCB Group, Inc.
PLATINUM SUPPORT:
Allergan, Inc.
Novartis
Pharmaceuticals
Teva Neurosciences, Inc.
For more information please contact Karen Bertani at
kbertani@sfneurological.org.
For more information:
Karen A. Bertani,
CMP
Executive Director
San Francisco Neurological Society
2226A Westborough Blvd. #409
South San Francisco, CA 94080
NEW
Tel: Phone: 415-206-9603; NEW Fax: 415-206-0385
E-mail:
kbertani@sfneurological.org
The San Francisco Neurological
Society is an organization of physicians with a dedicated interest in
the clinical neurosciences. The Society is committed to the continuing
medical education of its members and has an obligation to its members and
to the public to provide ongoing educational programs designed to improve
patient care and foster scholarly activity in the neurosciences. This
obligation includes not only imparting to the membership an increased
understanding of neurological diseases through lectures on clinical and
basic research, but also making them aware of community and public health
issues related to neurological illnesses and preventive medicine. The
Society is a CMA-accredited provider. Physicians attending this course may
report up to 8 hours of Category 1 credit toward the California Medical
Association Certificate in Continuing Medical Education and the American
Medical Association’s Physician’s Recognition Award.
|
|
Home
Registration
Newsletters/Photos
Support
Board of
Directors
Related Links
|
